These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30843120)

  • 1. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.
    Nierop PMH; Galjart B; Höppener DJ; van der Stok EP; Coebergh van den Braak RRJ; Vermeulen PB; Grünhagen DJ; Verhoef C
    Clin Exp Metastasis; 2019 Apr; 36(2):109-118. PubMed ID: 30843120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
    Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
    Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
    Liang JY; Xi SY; Shao Q; Yuan YF; Li BK; Zheng Y; Wang DS; Wu XJ; Ding PR; Chen G; Li LR; Wang FH; Wang ZQ; Pan ZZ; Xu RH; Li YH
    Cancer Immunol Immunother; 2020 Dec; 69(12):2623-2634. PubMed ID: 32601799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases.
    Meyer YM; Wilting SM; Kraan J; Olthof P; Vermeulen P; Martens J; Grünhagen DJ; Sleijfer S; Verhoef C
    Clin Exp Metastasis; 2023 Feb; 40(1):69-77. PubMed ID: 36326981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
    Filipe WF; Meyer YM; Buisman FE; van den Braak RRJC; Galjart B; Höppener DJ; Jarnagin WR; Kemeny NE; Kingham TP; Nierop PMH; van der Stok EP; Grünhagen DJ; Vermeulen PB; Groot Koerkamp B; Verhoef C; D'Angelica MI
    Ann Surg Oncol; 2023 Dec; 30(13):7996-8005. PubMed ID: 37782413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Histopathological Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases.
    Kanno H; Hisaka T; Fujiyoshi K; Akiba J; Hashimoto K; Fujita F; Akagi Y
    Ann Surg Oncol; 2023 May; 30(5):3139-3147. PubMed ID: 36520232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
    Bohlok A; Duran Derijckere I; Azema H; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Vierasu I; Goldman S; Flamen P; Larsimont D; Demetter P; Dirix L; Vermeulen P; Donckier V
    J Surg Oncol; 2021 May; 123(8):1773-1783. PubMed ID: 33751583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
    Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
    J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
    Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
    Nierop PMH; Höppener DJ; van der Stok EP; Galjart B; Buisman FE; Balachandran VP; Jarnagin WR; Kingham TP; Allen PJ; Shia J; Vermeulen PB; Groot Koerkamp B; Grünhagen DJ; Verhoef C; D'Angelica MI
    HPB (Oxford); 2020 Jun; 22(6):911-919. PubMed ID: 31735649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases.
    Bohlok A; Inchiostro L; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Craciun L; Demetter P; Larsimont D; Dirix L; Vermeulen P; Donckier V
    Eur J Surg Oncol; 2023 Jan; 49(1):217-224. PubMed ID: 36031469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
    Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
    Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection.
    Sanyal S; Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D
    J Gastrointest Cancer; 2021 Mar; 52(1):106-112. PubMed ID: 31853827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.
    Nierop PM; Höppener DJ; Buisman FE; van der Stok EP; Galjart B; Balachandran VP; Jarnagin WR; Kingham TP; Shia J; Mauer M; Nordlinger B; Julié C; Groot Koerkamp B; Doukas M; Vermeulen PB; Grünhagen DJ; D'Angelica MI; Verhoef C
    J Pathol Clin Res; 2022 Jan; 8(1):48-64. PubMed ID: 34480530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.
    Buisman FE; van der Stok EP; Galjart B; Vermeulen PB; Balachandran VP; Coebergh van den Braak RRJ; Creasy JM; Höppener DJ; Jarnagin WR; Kingham TP; Nierop PMH; Sadot E; Shia J; Groot Koerkamp B; Grünhagen DJ; D'Angelica M; Verhoef C
    Clin Exp Metastasis; 2020 Oct; 37(5):593-605. PubMed ID: 32691187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.
    Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL
    Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.